QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors

被引：0
|
作者：
P Ghatalia
Y Je
M D Kaymakcalan
G Sonpavde
T K Choueiri
机构：
[1] University of Alabama at Birmingham (UAB),Department of Internal Medicine
[2] Kyung Hee University,Department of Food and Nutrition
[3] Dana Farber Cancer Institute and Harvard Medical School,Department of Internal Medicine
[4] Section of Medical Oncology,undefined
[5] UAB Medical Center,undefined
来源：
British Journal of Cancer | 2015年 / 112卷
关键词：
vascular endothelial growth factor receptor; tyrosine kinase inhibitors; approved; QTc interval prolongation; meta-analysis; cardiac toxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：296 / 305
页数：9
相关论文
共 50 条
  • [21] Molecular modeling studies of vascular endothelial growth factor receptor tyrosine kinase inhibitors using QSAR and docking
    Du, Juan
    Lei, Beilei
    Qin, Jin
    Liu, Huanxiang
    Yao, Xiaojun
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2009, 27 (05): : 642 - 654
  • [22] Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: Design, synthesis, and evaluations
    Harmange, Jean-Christophe
    Weiss, Matthew M.
    Germain, Julie
    Polverino, Anthony J.
    Borg, George
    Bready, James
    Chen, Danlin
    Choquette, Deborah
    Coxon, Angela
    DeMelfi, Tom
    DiPietro, Lucian
    Doerr, Nicholas
    Estrada, Juan
    Flynn, Julie
    Graceffa, Russell F.
    Harriman, Shawn P.
    Kaufman, Stephen
    La, Daniel S.
    Long, Alexander
    Martin, Matthew W.
    Neervannan, Sesha
    Patel, Vinod F.
    Potashman, Michele
    Regal, Kelly
    Roveto, Phillip M.
    Schrag, Michael L.
    Starnes, Charlie
    Tasker, Andrew
    Teffera, Yohannes
    Wang, Ling
    White, Ryan D.
    Whittington, Douglas A.
    Zanon, Roger
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (06) : 1649 - 1667
  • [23] Cardiotoxicity of Selected Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Renal Cell Carcinoma
    Franczyk, Beata
    Rysz, Jacek
    Lawinski, Janusz
    Cialkowska-Rysz, Aleksandra
    Gluba-Brzozka, Anna
    BIOMEDICINES, 2023, 11 (01)
  • [24] Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer
    Subramanian, Janakiraman
    Morgensztern, Daniel
    Govindan, Ramaswamy
    CLINICAL LUNG CANCER, 2010, 11 (05) : 311 - 319
  • [25] Treatment of Newborn Mice with Inhibitors of Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Induces Abnormal Retinal Vascular Patterning
    Morita, Akane
    Nakahara, Tsutomu
    Ushikubo, Hiroko
    Mori, Asami
    Sakamoto, Kenji
    Ishii, Kunio
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2014, 37 (12) : 1986 - 1989
  • [26] Vascular Endothelial Growth Factor Polymorphisms: Role in Response and Toxicity of Tyrosine Kinase Inhibitors
    Vaziri, Susan A. J.
    Kim, Jenny
    Ganapathi, Mahrukh K.
    Ganapathi, Ram
    CURRENT ONCOLOGY REPORTS, 2010, 12 (02) : 102 - 108
  • [27] Vascular Endothelial Growth Factor Polymorphisms: Role in Response and Toxicity of Tyrosine Kinase Inhibitors
    Susan A. J. Vaziri
    Jenny Kim
    Mahrukh K. Ganapathi
    Ram Ganapathi
    Current Oncology Reports, 2010, 12 : 102 - 108
  • [28] Weight loss induced by tyrosine kinase inhibitors of the vascular endothelial growth factor pathway
    Desar, Ingrid M. E.
    Thijs, Annemarie M. J.
    Mulder, Sasja F.
    Tack, Cees J. J.
    van Herpen, Carla M. L.
    van der Graaf, Winette T. A.
    ANTI-CANCER DRUGS, 2012, 23 (02) : 149 - 154
  • [29] Inhibitors of the vascular endothelial growth factor receptor
    Rosen, LS
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2002, 16 (05) : 1173 - +
  • [30] THE FMS-LIKE TYROSINE KINASE, A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR
    DEVRIES, C
    ESCOBEDO, JA
    UENO, H
    HOUCK, K
    FERRARA, N
    WILLIAMS, LT
    SCIENCE, 1992, 255 (5047) : 989 - 991
12345